
Azithromycin Dihydrate by Zyntex is a highly stable crystalline form of the macrolide antibiotic (CAS 117772-70-0). It is a key active pharmaceutical ingredient (API) favored for its superior formulation stability in tablets and oral liquids.
Exceptional pharmacokinetic properties and high intracellular concentrations provide a major advantage in treating stubborn infections. Azithromycin Dihydrate works by preventing the translocation of peptide chains, making it a “gold standard” in the manufacturing of treatments for respiratory and soft tissue infections. It helps pharmaceutical companies create effective “3-day” or “5-day” antibiotic regimens. For instance, it is a primary component in producing therapy for acute bacterial sinusitis and bronchitis. Consequently, it enhances patient compliance through its convenient dosing profile. As a result, Zyntex ensures rigorous control over the hydration state and particle size distribution for our supply. This ensures maximum dissolution rates and consistent bioavailability in your final dosage forms.
Moreover, Zyntex supplies specialized Azithromycin Dihydrate for the veterinary healthcare sector. This compound acts as a critical agent in treating feline and canine respiratory diseases. It pushes the boundaries of veterinary medicine by offering a well-tolerated alternative to older macrolides. At the same time, it serves as a vital tool in combating multidrug-resistant strains in controlled clinical settings. In short, our product serves as a dependable “molecular antimicrobial shield.” It supports both the high-volume production needs of generic manufacturers and the precision requirements of innovative drug development labs.
Recently, scientific interest in Azithromycin Dihydrate for its potential anti-viral and anti-inflammatory synergy in respiratory distress cases has grown. It provides high efficacy in modulating the host immune response. Because of this, Zyntex offers grades that strictly adhere to current GMP, USP, and EP pharmacopeia standards. These formats suit modern high-speed encapsulation and automated packaging lines. Ultimately, choosing Zyntex secures a reliable and transparent pharmaceutical supply chain. We balance deep API expertise with rigorous batch-to-batch HPLC and XRD quality monitoring. To conclude, our commitment ensures your manufacturing processes achieve the highest levels of performance and stability.
This stable antibiotic hydrate is vital in these four sectors:
Primary API for tablets and capsules. Thus, it is the preferred form for solid dose manufacturing due to its crystalline stability.
Ideal for dry powders for oral suspension. Consequently, it is vital for creating shelf-stable liquid medications for children.
Used in broad-spectrum animal antibiotics. Undoubtedly, it is essential for the effective treatment of pet and livestock infections.
Acts as a reference for azalide class studies. Specifically, it supports the discovery of new antimicrobial mechanisms.
| Parameter | Standard Value |
|---|---|
| Product Name | Azithromycin Dihydrate |
| Molecular Formula | $C_{38}H_{72}N_{2}O_{12} cdot 2H_{2}O$ |
| Molecular Weight | 785.02 g/mol |
| CAS Number | 117772-70-0 |
⚠️ Safety & Handling: Azithromycin Dihydrate should be handled in compliance with pharmaceutical safety protocols. Therefore, wear a dust mask, nitrile gloves, and safety glasses to prevent accidental exposure. Not for direct consumption; intended for manufacturing use only. Store in a cool, dry place in airtight containers to preserve the specific hydration state and potency.